Sign In
Buy MRVI
$4.84
+0.0100 (+0.207%)
At Close: Jun 03, 2026
Maravai LifeSciences Holdings, Inc. (MRVI) Lags Q1 Earnings and Revenue Estimates
07:02pm, Monday, 08'th May 2023
Maravai LifeSciences Holdings, Inc. (MRVI) came out with quarterly earnings of $0.03 per share, missing the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.54 per share a
Maravai LifeSciences To Host Earnings Conference Call on Monday, May 8, 2023
04:15pm, Monday, 17'th Apr 2023
SAN DIEGO, April 17, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans
2 Top Biotech Stocks to Buy In March and Hold Forever
08:45am, Monday, 13'th Mar 2023
Long-term investments in biotech tend to be hard to come by. Moderna's gargantuan pipeline means that it has a very long growth runway ahead.
Maravai LifeSciences Announces March 2023 Investor Conference Schedule
08:00am, Wednesday, 08'th Mar 2023
SAN DIEGO, March 08, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, is scheduled to
Maravai LifeSciences Holdings, Inc. (MRVI) Q4 2022 Earnings Call Transcript
09:37pm, Wednesday, 22'nd Feb 2023
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q4 2022 Earnings Conference Call February 22, 2023 5:00 PM ET Company Participants Debra Hart - Head of Investor Relations Carl Hull - Interim Chief
Maravai LifeSciences Holdings, Inc. (MRVI) Tops Q4 Earnings Estimates
07:34pm, Wednesday, 22'nd Feb 2023
Maravai LifeSciences Holdings, Inc. (MRVI) delivered earnings and revenue surprises of 2.94% and 0.30%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead
Earnings Preview: Maravai LifeSciences Holdings, Inc. (MRVI) Q4 Earnings Expected to Decline
11:17am, Wednesday, 15'th Feb 2023
Maravai LifeSciences Holdings, Inc. (MRVI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Maravai LifeSciences to Host Earnings Conference Call on Wednesday, February 22, 2023
08:00am, Wednesday, 01'st Feb 2023
SAN DIEGO, Feb. 01, 2023 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
3 Great Growth Stocks Down 20% or More to Buy Now
09:37am, Friday, 27'th Jan 2023
These beaten-down stocks could be poised for major rebounds.
3 Biopharma Stocks That Could Help Make You a Fortune
08:30am, Monday, 16'th Jan 2023
All three are protected by sales of in-demand products, with more on the way.
These Were The Five Best And Worst Performing Mid-Cap Stocks In October 2022
08:22pm, Tuesday, 15'th Nov 2022
Mid-cap companies lie in between the slower growth large-cap stocks and the faster-growth small-cap businesses.
Maravai LifeSciences Holdings, Inc. (MRVI) Q3 2022 Earnings Call Transcript
10:56pm, Wednesday, 02'nd Nov 2022
Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q3 2022 Results Conference Call November 2, 2022 5:00 PM ET Company Participants Deb Hart - Head of Investor Relations Carl Hull - Interim Chief Exec
This Fallen Growth Stock Is Still a Wall Street Favorite: Here's Why
08:45am, Saturday, 29'th Oct 2022
It's positioned to benefit from the emergence of a new, long-term trend in biopharma.
Maravai LifeSciences: Establishing The Diagnosis
05:36am, Saturday, 22'nd Oct 2022
Maravai has seen a real boom from the pandemic. Sales could likely see pressure in 2023, even as underlying non-pandemic related growth seems solid.
Maravai LifeSciences To Host Earnings Conference Call on Wednesday, November 2, 2022
04:15pm, Tuesday, 18'th Oct 2022
SAN DIEGO, Oct. 18, 2022 (GLOBE NEWSWIRE) -- Maravai LifeSciences, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, plans t
